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G erm cells face a number of major fate decisions during their development. One is self-renewal or differentiation; another is how to differentiate as a gamete of a particular sex, in animal sperm or egg; and a third is a cell cycle decision-to leave the mitotic cell cycle and enter the meiotic cell cycle, or more simply, the mitosis/meiosis decision. A longstanding puzzle in germ cell biology has been to understand the regulatory relationships among these three fate decisions. How are germ cells controlled to leave their stem cell mode in the mitotic cell cycle and then enter the meiotic cell cycle and mature as sperm or egg? Our understanding of this complex process comes largely from model animals-the nematode Caenorhabditis elegans, fruit fly Drosophila melanogaster, and mouse Mus musculus, as well as model plants-the dicot Arabidopsis thaliana and monocots maize Zea mays and rice Oryza sativa. Although the regulatory circuitry remains fragmentary in virtually all these multicellular organisms, unifying themes have begun to emerge. The major advances made over the past decade have answered central questions and posed new or clearer questions that will likely shape the field in the coming few years. incorporated into two diploid daughters. S-phase is preceded by G 1 , a stage when key developmental controls are exerted, and it is followed by G 2 , a stage characterized by growth and preparation for M-phase. In animals, primordial germ cells (PGCs) proliferate using the mitotic cell cycle in embryos, and adult germline stem cells (GSCs) rely on the mitotic cycle for self-renewal and amplification via trans-amplifying cells.
As germ cells begin to mature, they transition from the mitotic cell cycle into the meiotic cell cycle, a process that ultimately reduces the number of chromosomes from two sets to one in both sperm and egg (Fig. 1) . Fertilization restores the two sets of chromosomes in the newly formed zygote, which then launches a new generation. The meiotic cell cycle begins with a "meiotic S-phase" during which the genome is replicated and a meiosis-specific cohesin complex is loaded onto chromosomes. This meiotic S-phase constitutes a first and crucial step in the meiotic cell cycle (e.g., Watanabe et al. 2001; Forsburg 2002) . After meiotic S-phase, germ cells enter an elaborate and protracted meiotic prophase I, during which sister chromatid pairing, synapsis, and recombination occur. The first easily visible hallmarks of the meiotic cell cycle are chromosome pairing and early steps in formation of the synaptonemal complex during leptotene and zygotene. These early meiosis-specific events are often detected by their characteristic nuclear morphology and by immunocytochemistry using antibodies against early meiotic prophase proteins (e.g., components of the synaptonemal complex).
MOLECULAR REGULATION OF THE MITOSIS/MEIOSIS DECISION IN SPECIFIC ORGANISMS
Our understanding of the mitosis/meiosis decision in multicellular creatures comes largely from focused studies in model organisms with each bringing its own perspective to bear on the mitosis/meiosis decision. Although many aspects of the mitotic and meiotic cell cycles are conserved during germ cell development, the transition from one to the other often takes place in an organism-specific or sex-specific context. As a result, the mitosis/meiosis decision is presented to the experimentalist in ways that have impacted how it has been approached in different organisms. We begin this section with a very brief summary of insights from single-celled yeasts, and then turn to the decision in multicellular organisms, emphasizing recent advances at the molecular level.
THE YEASTS: DIVERSE MOLECULAR MECHANISMS OF MITOSIS/MEIOSIS REGULATION
Elaborate regulatory circuitries control the mitosis/meiosis decisions in the budding yeast Saccharomyces cerevisiae and the fission yeast Universal features of mitotic and meiotic germ cell cycles. Mitotic divisions duplicate diploid germ cells (yellow cells, 2 depicts diploidy), whereas meiotic divisions generate haploid germ cells (green cells, 1 depicts haploidy). The red arrow shows that the decision to leave the mitotic cell cycle and enter the meiotic cell cycle occurs prior to meiotic S-phase. Meiotic prophase I progresses from its earliest stages (crescent depicts chromosomal bouquet), through pachytene (wavy lines depict synapsed chromosomes), to later stages (chromosomal bivalents) that line up at the metaphase plate at meiosis division I.
Schizosaccharomyces pombe. Genes regulating the mitosis/meiosis decision were initially recognized in mutants that continue mitotic divisions under conditions that normally signal meiotic entry, or conversely in mutants that aberrantly enter the meiotic cycle when mitotic divisions are the norm. A common theme is that the nutritional environment combines with sex determination regulators to ensure that yeast cells enter the meiotic cell cycle only when they are in a diploid state and find themselves without sufficient nutrition.
S. cerevisiae
The mitosis/meiosis decision is arguably best understood in the budding yeast, S. cerevisiae. The IME1 transcription factor acts in late G 1 or at the G 1 /S transition to activate the transcription of genes in the early meiotic genetic program and to initiate meiotic S-phase (Mitchell 1994; Vershon and Pierce 2000; Kassir et al. 2003) . The regulation of IME1 is accomplished by nutritional cues and other inputs. For example, only diploid cells enter the meiotic cell cycle, and it is two key sex determination regulators (known in yeasts as mating type regulators) that register the diploid state: a1/ a2 represses an ime1 repressor and thereby activates the meiotic program. Manipulation of nutritional cues reveals that the mitosis/meiosis decision must be maintained. Thus, starvation of diploid cells induces entry into the meiotic cell cycle, but a return to rich medium can reverse the decision and return the cell to the mitotic cell cycle; indeed "commitment" to progression through meiotic prophase I can be reversed until the first meiotic division (Simchen 2009). See reviews for additional information about this paradigm of regulatory circuitry (Mitchell 1994; Kassir et al. 2003) .
S. pombe
The mitosis/meiosis decision in the fission yeast, S. pombe, also relies on nutrition and sex determination, but in this case, the terminal regulators of meiotic entry are not transcription factors. Instead, nutritional cues and mating-pheromone signaling trigger an elaborate cascade that ultimately controls activity of the Mei2 RNA-binding protein. Mei2 works together with the noncoding meiRNA to initiate meiotic S-phase and also to promote subsequent events in early meiotic prophase I (Watanabe and Yamamoto 1994) . Whereas meiotic mRNAs are eliminated during the mitotic cell cycle, Mei2 and meiRNA antagonize that elimination and induce meiotic entry (Harigaya et al. 2006) . See reviews for additional information about this intriguing mechanism of mitosis/meiosis control (Yamamoto 1996; Harigaya and Yamamoto 2007) .
C. ELEGANS: STEM CELL CONTROLS MEET THE MITOSIS/MEIOSIS DECISION
The C. elegans mitosis/meiosis circuitry is closely linked to controls of germline self-renewal and differentiation. As in yeast, nematode regulators of the mitosis/meiosis decision were identified in mutants that transform mitotic germ cells into the meiotic cell cycle or vice versa. These C. elegans transformations dramatically affect germline self-renewal and differentiation in addition to their effects on the mitosis/meiosis decision. When germ cells are driven aberrantly from the mitotic into the meiotic cell cycle, germline stem cells (GSCs) are lost, and conversely when germ cells aberrantly continue the mitotic cell cycle at the expense of meiotic entry, a germline tumor results.
Background to C. elegans GSCs and Mitosis/Meiosis Decision C. elegans can develop as either an XX selffertilizing hermaphrodite or an XO male. In both sexes, GSCs proliferate from two to 1000 germ cells during larval development (Kimble and White 1981) ; they maintain a constant number of germ cells in adults, while at the same time generating a steady stream of gametes (Crittenden et al. 2006; Morgan et al. 2010) . A stem cell niche of somatic origin resides at the distal end of the germline tissue and is responsible for both larval GSC proliferation and adult GSC self-renewal (Kimble and White 1981; Morgan et al. 2010) . In adults, 35-70 mitotic germ cells at the distal-most end are maintained in an essentially equivalent stem cell-like state; more proximally, transitamplifying germ cells remain in the mitotic cell cycle but are organized in a distal-toproximal gradient of increasing maturation ( Fig. 2A) (Cinquin et al. 2010) . Therefore, the meiotic program is triggered before germ cells leave the mitotic cell cycle and overtly enter meiotic S-phase. Even more proximally, all germ cells have entered meiotic S-phase or progressed into early stages of meiotic prophase I ( Fig. 2A) . When late larvae are starved, they metabolize most of their germline tissue, with only 35 GSCs remaining to replenish the entire tissue and generate progeny after refeeding during adulthood (Angelo and Van Gilst 2009) . The molecular regulation of GSCs and the mitosis/meiosis decision have been analyzed in well-fed animals, but this recent result shows unequivocally that nutritional cues have a major impact. Consistent with this idea, insulin signaling can affect the extent of larval GSC proliferation (Michaelson et al. 2010) . 
Regulators that Promote Germline Self-Renewal Directly Repress the Meiotic Program
Notch signaling and two PUF (for Pumilio and FBF) RNA-binding proteins maintain germline self-renewal and also promote continued mitotic divisions at the expense of meiotic entry ( Fig. 2B ) (e.g., Kimble and Crittenden 2007) . A Notch ligand from the niche keeps GSCs in the mitotic cell cycle and in a stem cell-like state. When signaled, the GLP-1/Notch receptor triggers transcriptional activation of target genes (Petcherski and Kimble 2000) . Two GLP-1/ Notch target genes relevant to the mitosis/ meiosis decision are fbf-2 (Lamont et al. 2004) and lip-1 ( Lee et al. 2006) . FBF-2 is discussed below. LIP-1 is the homolog of a dual specificity phosphatase that normally delays meiotic entry, probably by inactivating MPK-1, the single C. elegans homolog of ERK/MAP kinase (Berset et al. 2001; Lee et al. 2006) . Other targets of Notch transcriptional activation must exist, because an fbf-2 lip-1 double-mutant maintains GSCs and supports a virtually normal mitosis/ meiosis decision. Importantly, both Notch signaling and FBF control GSCs and the mitosis/ meiosis decision in both sexes during adulthood-when XX germlines are oogenic and XO germlines are spermatogenic. Two nearly identical PUF proteins, FBF-1 and FBF-2 (collectively known as FBF), function within germ cells to regulate both selfrenewal and the mitosis/meiosis decision ( Fig. 2B ) (e.g., Kimble and Crittenden 2007) . FBF prevents meiotic entry by directly repressing the expression of a battery of mRNAs critical to the meiotic program, including regulators of meiotic entry (gld mRNAs, see below) as well as components of the meiotic machinery (e.g., synaptonemal complex formation, recombination) (Crittenden et al. 2002; Eckmann et al. 2004; Merritt et al. 2008; Kershner and Kimble 2010; Merritt and Seydoux 2010) . In addition to its direct control of the meiotic program, FBF also represses mpk-1 mRNA, lin-3 mRNA, and fog-1 mRNA, which encode the C. elegans homologs of ERK/MAP kinase, TGF-a/EGF, and CPEB, respectively (Fig. 2B ) (Thompson et al. , 2006 Lee et al. 2007a; Kershner and Kimble 2010) . MPK-1 and LIN-3 regulate multiple cell fates in somatic tissues (Sundaram 2006) ; MPK-1 also affects germ cell fate specification (Lee et al. 2007b) ; FOG-1 is one of the terminal regulators of sperm fate specification (Barton and Kimble 1990) . Indeed, FBF has at least 1350 likely targets, many of which encode potent regulators of differentiation (Kershner and Kimble 2010) . Therefore, FBF appears to maintain GSCs in a naïve stem cell -like state by repressing a broad spectrum of differentiation regulators, including those in the meiotic program.
Regulators that Promote Meiotic Entry Oppose Germline Self-Renewal and the Mitotic Cell Cycle
Three GLD proteins drive germ cells into the meiotic cell cycle (Fig. 2B ) (Kadyk and Kimble 1998; Eckmann et al. 2004; Hansen et al. 2004 ). These GLD proteins form two branches of control, with GLD-1 in one branch and GLD-2/GLD-3 in the other branch. Importantly, the two GLD branches control meiotic entry in both XX and XO animals (Kadyk and Kimble 1998) ; therefore, regulation of meiotic entry appears to be gender-neutral.
GLD-1 is a translational repressor (Lee and Schedl 2010) that controls regulators of both self-renewal and the mitotic cell cycle. Its direct targets include mRNAs encoding the GLP-1/ Notch receptor and cyclin E (Marin and Evans 2003; Biedermann et al. 2009 ). GLD-1 also maintains commitment to progression through the meiotic cell cycle; germ cells revert to mitotic divisions and form a germline tumor in gld-1 single mutants (Francis et al. 1995; Subramaniam and Seydoux 2003; Biedermann et al. 2009 ); indeed within that tumor, germ cells can trans-differentiate into a variety of somatic cell types (Ciosk et al. 2006) . Therefore, GLD-1 promotes meiotic entry and also maintains germ cells in a totipotent state during meiotic progression.
The GLD-2/GLD-3 heterodimer is a cytoplasmic poly(A) polymerase and translational activator (Wang et al. 2002; Suh et al. 2006 ).
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One direct target of GLD-2/GLD-3 activation is the gld-1 mRNA, a regulatory link that provides positive feed-forward to drive meiotic entry (Suh et al. 2006) ; other direct targets are not yet known but must exist because GLD-2/ GLD-3 promotes meiotic entry in gld-1 null mutants. Like the GLD-1 regulator, GLD-2 and GLD-3 also govern meiotic progression, but their roles are distinct (Kadyk and Kimble 1998; Eckmann et al. 2002) .
Shifting the Balance between Mitotic and Meiotic Modes of the Network
The FBF and GLD proteins form major hubs in the network of mitosis/meiosis control and the nature of those hubs confers plasticity on the decision (Kimble and Crittenden 2007) . Feedback within the network is provided by GLD-1 repression of Notch signaling (Marin and Evans 2003) and FBF negative auto-and crossregulation (Lamont et al. 2004 ). When either FBF-1 or FBF-2 is removed, the other FBF is up-regulated and GSCs are maintained, but when both are removed, GSCs are lost. Similarly, when only one GLD branch is removed, meiotic entry occurs, albeit abnormally, but when both branches are removed a germline tumor results. Intriguingly, the individual FBFs affect the balance between mitotic and meiotic modes differently, probably because of the gene-specific regulation of the two proteins (Crittenden et al. 2002; Lamont et al. 2004) . In addition to the FBFs and GLDs, other regulators also shift the number of mitotically dividing germ cells (e.g., LIP-1, see above). This redundancy and modulation renders the mitosis/meiosis decision both robust and plastic, features that permit its regulatory network to respond to varying inputs (e.g., gender, aging, stress, pathogenesis, natural selection).
Many other regulatory proteins influence GSC mitotic divisions and the mitosis/meiosis balance (Kimble and Crittenden 2005; van den Heuvel 2005) . The canonical cell cycle machinery controls GSC mitotic divisions, as expected; in addition, many RNA regulatory proteins affect the mitosis/meiosis balance, underscoring the importance of posttranscriptional controls of C. elegans germ cell cycles (e.g., Belfiore et al. 2004; Ciosk et al. 2004; Eckmann et al. 2004; Maine et al. 2004; Hansen et al. 2005; Hasegawa et al. 2006; Ariz et al. 2009; Kerins et al. 2010 ). In addition, micro RNAs have been implicated in GSC proliferation controls (Cox et al. 1998; Smardon et al. 2000) . Elucidation of the complete molecular network controlling the C. elegans mitosis/meiosis decision is clearly a work in progress.
DROSOPHILA: CYST FORMATION MEETS THE MITOSIS-MEIOSIS DECISION
The Drosophila germline tissue is organized with stem cells at one end and differentiating gametes at the other (Fig. 3A , male germline). Although male and female germlines differ in many respects, some striking similarities do exist. In both sexes, GSCs divide asymmetrically to produce one GSC daughter and one daughter destined to differentiate; the latter is called a "cystoblast" in females and a "gonialblast" in males. The cystoblast/gonialblast then generates a 16-cell cyst in both sexes. In males, meiotic S-phase occurs in the germ cells of the 16-cell cyst and their meiotic divisions generate 64 sperm. In females, two of the germ cells in the 16-cell cyst enter the meiotic cell cycle and one of those goes on to generate a single egg; the 15 others become nurse cells. Regulation of the GSC -cystoblast/gonialblast decision has been elucidated in exquisite detail in both males and females (see Davies and Fuller 2008; Zhang and Xie 2009) . Importantly, two key regulators of that early decision also control meiotic entry in the germ cells of the 16-cell cyst and appear to do so in both sexes.
The bag-of-marbles (bam) and benign gonial cell neoplasm (bgcn) proteins function in both males and females to promote "postcyst" differentiation, including meiotic entry (Fig. 3B ) (McKearin and Spradling 1990; Gönczy et al. 1997; Insco et al. 2009 ). Germ cells lacking either bam or bgcn undergo extra rounds of mitotic division and fail to enter the meiotic cell cycle. Moreover, GSCs exposed to ectopic Bam protein are induced to differentiate (Ohlstein and McKearin 1997) . The Bam molecular function was not apparent from its amino acid sequence (McKearin and Spradling 1990), but bgcn is related to DExH proteins, suggesting a role in RNA regulation (Ohlstein et al. 2000) . Indeed Bam and bgcn form a complex that binds and antagonizes both Pumilio and eIF4A proteins and that also regulates the Nanos mRNA via its 3 0 UTR (Li et al. 2009; Shen et al. 2009; Kim et al. 2010) . Therefore, Bam/bgcn functions posttranscriptionally.
The transition from mitotic germ cell divisions within the cyst into meiotic S-phase normally occurs at the 16-cell stage. In Drosophila testes, Bam is normally expressed in 4-, 8-, and 16-cell cysts; its levels peak in 8-cell cysts, continue at a lower level in early 16-cell cysts that are in meiotic S-phase, and drop precipitously in later 16-cell cysts that have completed DNA replication (Insco et al. 2009 ). Manipulations of Bam dosage dramatically affect the timing of meiotic entry. In bam/þ heterozygotes, Bam peaks later than normal and the switch into meiosis occurs late, resulting in 32-cell and .32-cell cysts; by contrast, a PEST-deleted mutant BAM peaks earlier than normal and the switch into meiosis occurs early, resulting in 8-cell cysts that go on to differentiate. Therefore, in Drosophila testes, the amount of Bam protein is crucial for determining the time at which cyst cells stop dividing mitotically and instead begin meiotic S-phase. Indeed, normal cyst formation relies on the Bam gradient extending between GSC and the site of meiotic entry (Fig. 3B ) (Insco et al. 2009 ).
BMP signaling down-regulates Bam expression in both male and female GSCs, and that down-regulation is crucial for GSC maintenance ( Fig. 3B) (Chen and McKearin 2003; Kawase et al. 2004) . Taking these results together, the Drosophila mitosis/meiosis decision appears to be integrated with controls of GSC self-renewal maintenance, much as it is in C. elegans. In addition to the few regulators mentioned here, which interface clearly with the mitosis/meiosis decision, many other regulators affect Drosophila GSC self-renewal and differentiation and therefore are implicated in the mitosis/meiosis decision.
MOUSE: SEX DETERMINATION MEETS THE MITOSIS/MEIOSIS DECISION
The murine mitosis/meiosis decision shows a dramatic sex-specific timing of meiotic entry that historically has been analyzed as a sex determination decision. The sex-specific difference 
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Cite this article as Cold Spring Harb Perspect Biol 2011;3:a002683 occurs soon after the primordial germ cells (PGCs) migrate into the fetal gonadal primordium, when all female PGCs enter the meiotic cell cycle and all male PGCs arrest at G 1 /G 0 of the mitotic cell cycle (Fig. 4A, left) . The female germ cells quickly progress through meiotic prophase I and arrest at metaphase of the first meiotic division, still within the fetal ovary; then after puberty, those female germ cells develop in cyclical fashion to produce mature oocytes. By contrast, male germ cells at puberty take on the dual task of maintaining spermatogonial stem cells and generating a continuous stream of sperm (Fig. 4A, right) . This striking sexspecific meiotic entry led to a major question in the field: Are mitosis/meiosis and sperm/ oocyte two decisions or only a single decision (Kimble and Page 2007) ? An answer to that question has now emerged through groundbreaking studies that have outlined central players in the murine mitosis/meiosis pathway.
Retinoic Acid and STRA8 Promote Meiotic Entry
Success in the hunt for murine regulators of the mitosis/meiosis decision began with two key discoveries. A target gene of retinoic acid signaling, STRA8 (stimulated by retinoic acid 8), was expressed sex-specifically in female fetal gonads at the time of female-specific meiotic entry (Oulad-Abdelghani et al. 1996; Koubova et al. 2006) , and the Cyp26b1 inhibitor of retinoic acid signaling was expressed sex-specifically in male fetal gonads at the same time (Bowles et al. 2006) . Both findings led investigators to the idea that retinoic acid (RA) might induce meiotic entry in the fetal ovary, whereas Figure 4 . The mouse mitosis/meiosis decision. (A) Meiotic entry (red arrow) occurs during fetal development in female mice and after puberty in males. PGCs (yellow) enter the fetal somatic gonad, which is sexually bipotential ( purple). Sex determination of the fetal somatic gonad results in a female (rose) or male (blue) somatic gonad; in these fetal developing gonads, female PGCs enter the meiotic cell cycle (green), whereas male PGCs arrest in the mitotic cell cycle (yellow). After puberty, female germ cells produce mature oocytes, whereas the male maintain spermatogonial stem cells (yellow), transit-amplifying cells (yellow) and meiotic cells (green) that produce mature sperm. No individual cross-section of the seminiferous tubule (dotted line) has all stages because of the wave of maturation along its length. (B) Molecular regulation of the murine mitosis/meiosis decision. Retinoic acid activates expression of STRA8, which governs meiotic entry by an unknown mechanism. NOS2 has been implicated in repression of the stra8 mRNA as well as mRNAs encoding the meiotic machinery. In the male fetal gonad, Cyp26b1 inhibits retinoic acid and blocks meiotic entry. Solid arrows and lines indicate direct molecular regulation; dashed line indicates control that may be either direct or indirect. degradation of retinoic acid might prevent meiotic entry in the fetal testis (Fig. 4B) . Subsequent experiments supported that model (Bowles et al. 2006; Koubova et al. 2006) . For example, RA addition to a fetal male gonad induced early markers of meiosis, including STRA8, and suppressed the pluripotency marker Oct4, whereas RA antagonists had the opposite effect. Moreover, germ cells in the fetal testis entered the meiotic cell cycle in a Cyp26b1 mutant. Therefore, RA is capable of driving both female and male fetal germ cells into meiosis.
STRA8 is expressed specifically in meiotic germ cells in the fetal ovary and in the juvenile testis, suggesting that STRA8 might act downstream from RA to induce meiotic entry in both sexes (Fig. 4B ) (Oulad-Abdelghani et al. 1996; Baltus et al. 2006; Anderson et al. 2008; Mark et al. 2008) . Indeed, in stra8 null mutants, germ cells fail to enter the meiotic cell cycle, both in fetal female gonads and juvenile male gonads (Baltus et al. 2006; Anderson et al. 2008 ). An alternate view, that STRA8 instead functions in early meiotic prophase, comes from a parallel analysis of a stra8 mutant (Mark et al. 2008) . The likely resolution is that STRA8 governs both initiation into the meiotic cell cycle and early meiotic progression, with genetic modifiers generating the different phenotypes. The STRA8 "novel" amino acid sequence includes a putative helix-loop-helix domain (Baltus et al. 2006) , and its subcellular localization encompasses both nucleus and cytoplasm (Oulad-Abdelghani et al. 1996; Tedesco et al. 2009 ). The idea that STRA8 may be a transcription factor has garnered some experimental support (Tedesco et al. 2009 ) but that conclusion is not yet confirmed. Most importantly, STRA8 is required for meiotic entry in both male and female germ cells, putting to rest the hypothesis that the mitosis/meiosis decision might be equivalent to the sperm/oocyte decision.
NOS2 and DAZ Also Influence the Fetal Mitosis/Meiosis Decision
Two conserved RNA binding proteins also influence the fetal mitosis/meiosis decision. The Nanos-related NOS2 protein prevents meiotic entry in fetal male germ cells and can be induced to do the same in fetal female germ cells when ectopically expressed (Fig. 4B ) (Suzuki and Saga 2008) . NOS2 is normally expressed in fetal male germ cells, just as Cy26b1 begins to decrease. In the absence of NOS2, male germ cells fail to maintain their G 0 /G 1 cell cycle arrest and appear to embark on the meiotic cell cycle, but eventually die. However, in a double mutant that removes both NOS2 and the BAX2 proapoptotic regulator, fetal male germ cells expressed STRA8 aberrantly and entered the meiotic cell cycle (Suzuki and Saga 2008) . Nanos proteins are translational repressors (Gray and Wickens 1998) , and NOS2 itself interacts with the CCR4-Not deadenylation complex (Suzuki et al. 2010) . Importantly, immunoprecipitation of a FLAGtagged NOS2 brings down stra8 mRNA along with other transcripts implicated in meiosis (e.g., sycp3) (Suzuki et al. 2010 ). The likely scenario is that NOS2 represses both a regulator of meiotic entry (stra8) plus critical components of the meiotic machinery (Fig. 4B) . In addition to NOS2, the DAZ (deleted in azoospermia) protein renders fetal germ cells of both sexes responsive to RA signaling (Lin et al. 2008) . Therefore, both NOS2 and DAZ are capable of influencing meiotic entry in murine germ cells of either sex.
PLANTS: GERMLINE/SOMA DECISION MEETS THE MITOSIS/MEIOSIS DECISION
An embryonic germline lineage does not exist in plants. Instead, individual germ cells are induced from somatic tissues in the developing flower (Walbot and Evans 2003) . Those germ cells, termed generically "sporocytes" in the two sexes or "megaspore mother cell" and "pollen mother cell" in females and males, respectively, typically enter into the meiotic cell cycle soon after their induction from the somatic hypodermal tissue. Therefore, meiotic entry is typically linked to germ cell specification in plants. However, in some mutant strains, germ cells can be specified and generate gametes without meiotic entry, a process termed apomixis (e.g., Ravi et al. 2008) . The germline/soma and Multiple regulators of germ cell specification and meiotic entry have been identified in Arabidopsis, maize, and rice (Ma 2005; Hamant et al. 2006; Mercier and Grelon 2008; Yang et al. 2010) . The analyses of these regulators have provided important clues about controls of meiotic entry in plants. First, extrinsic signaling induces germ cell differentiation, including meiotic entry. In both the Arabidopsis dicot and rice monocot, a leucine-rich repeat receptor-like protein kinase controls germ cell induction (reviewed in Ma 2005) , suggesting an ancient signaling mechanism among plants. Second, intrinsic regulators control meiotic entry or early meiotic prophase in both ovules and anthers (Motamayor et al. 2000; Mercier et al. 2003; Pawlowski et al. 2009 ). These include the Arabidopsis SWITCH1 and maize AMEIOTIC1 genes, which encode homologous plant-specific proteins that localize to the nucleus. SWITCH1 is required for the normal pattern of histone modifications, suggesting a role in chromatin modification (Boateng et al. 2008) . Similarly, a germ cell specific Argonaute controls both early meiotic prophase and histone modifications in rice (Nonomura et al. 2007 ). Therefore, chromatin modification has been implicated as a likely molecular mechanism that influences meiotic entry in all three model plants.
EMERGING THEMES
Recent advances in understanding molecular controls of the mitosis/meiosis decision reveal several unifying themes. Some of those themes extend to yeast and plants, whereas others appear specific to metazoans. Rather than repeat references here, readers are referred for the most part to individual sections above for citations. 3. Key regulators of meiotic entry are genderneutral. The mitosis/meiosis decision can differ in the two sexes in a variety of ways, including timing and position of meiotic entry. Yet the same central regulators control meiotic entry in both sexes in C. elegans, mice, plants, and probably Drosophila. Because the mitosis/ meiosis decision in C. elegans is not dramatically different in the two sexes, it was not surprising that gender-neutral regulators controlled the decision. However, in mice, where the decision is dramatically different in the two sexes, the discovery of regulators that control meiotic entry in both sexes was a real surprise and major breakthrough. The emerging theme is that gender-neutral regulators of the mitosis/meiosis decision can be modulated to drive meiotic entry in a sex-specific manner.
4. A close relationship exists between GSC selfrenewal and mitosis/meiosis controls in animals. GSC loss occurs aberrantly in C. elegans and Drosophila on removal of self-renewal regulators, and it occurs naturally in female mammals during fetal development. In all three cases, GSC loss is accompanied by the meiotic entry and differentiation of all germ cells. In C. elegans and Drosophila, molecular regulators of GSC self-renewal and meiotic entry are directly antagonistic. In mice, pluripotency factors (e.g., Oct4) are similarly antagonistic with RA signaling and STRA8, although the mechanism of that interaction
is not yet known (Bowles and Koopman 2007) .
5. Commitment to the meiotic cell cycle must be actively maintained. S.cerevisiae and C.elegans cells can enter the meiotic cell cycle and progress into pachytene, but then return to mitotic divisions, suggesting that commitment to the meiotic cell cycle must be actively maintained. In Drosophila, spermatogonial cells can dedifferentiate into GSCs (Sheng et al. 2009 ), suggesting a similar need for active maintenance of meiotic progression in flies. An irreversible commitment to meiosis only occurs at the meiosis I division in S. cerevisiae and may be similarly late in C. elegans.
OPEN QUESTIONS
The major advances made in understanding the mitosis/meiosis decision over the past decade have answered some key questions and opened the door to others. (Hsu et al. 2008 ), but its effect on the mitotic/meiotic decision has not yet been reported. The broader role of nutrition on the mitosis/meiosis decision in multicellular creatures is virtually virgin territory for future exploration.
5. What is the clinical impact of understanding the mitosis/meiosis decision? Understanding the mitosis/meiosis decision has clear implications for human fertility and germ cell tumors. For example, in adult men, the mitotic and meiotic cell cycles are normally kept in a tightly controlled balance between spermatogonial stem cells (SSCs) and maturing spermatocytes. If that balance is tipped aberrantly toward meiotic entry, SSCs are depleted, and if tipped toward mitotic divisions, uncontrolled germ cell proliferation and perhaps cancer result. An in depth understanding of the molecular mechanisms that modulate the balance will therefore be crucial for developing therapies that impact human reproduction and health. One possible example might be the development of a male contraceptive that is based on the inhibition of molecular events specific to the mitosis/ meiosis decision. Vitamin A depletion renders males sterile and its effects can be reversed-but Vitamin A depletion affects many tissues deleteriously. The generation of a drug that targets a germ cell-specific component of the pathway (e.g., STRA8) might be equally effective but have few side effects.
CONCLUSIONS AND PERSPECTIVES
Our understanding of the mitosis/meiosis decision in germ cells of multicellular organisms has been transformed during the past 5 years. One conceptual breakthrough is that mitosis/meiosis regulators are gender-neutralthey control meiotic entry in the germ cells of both sexes. This basic idea holds true in nematodes, mice, plants, and probably flies. The dramatic sex-specific timing of the mammalian mitosis/meiosis decision, which historically was equated with the sperm/oocyte decision, actually relies on sex-specific regulation of the gender-neutral mitosis/meiosis regulators. A second conceptual breakthrough is that regulators of germline stem cells control entry into the meiotic cell cycle as part of their larger program to maintain the stem cells in a naïve, undifferentiated state. Plants do not have germline stem cells, per se, but instead possess totipotent somatic cells that may play a similar but plantspecific role. The relationship between stem cell and mitosis/meiosis regulators may therefore be specialized for animal germ cells. The decision of a germ cell to progress through either the mitotic or the meiotic cell cycle is an ancient one with important implications for reproduction and health in humans and improved methods of agriculture in plants. Although breakthroughs have been made, our molecular understanding of the mitosis/meiosis decision remains in its infancy. The next decade will expand our knowledge of the mitosis/ meiosis molecular circuitry in multiple organisms and clarify the relationship of that circuitry with GSC controls, totipotency controls, and the sperm/oocyte decision.
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